Morgan Stanley
-
State Bank of India will pick up to six firms for a proposed qualified institutional placement or follow-on public offer, according to a request for proposals sent on Tuesday. -
Australian billionaire James Packer has cashed in his remaining stake in his Macau joint venture with Hong Kong gaming tycoon Lawrence Ho, netting $1.2bn in the process.
-
Chile’s leading casino operator Enjoy SA spent Monday receiving feedback from investors about certain modified terms on its offering memorandum after potential bond buyers decided that the original terms were too risky a bet.
-
Books for Bright Scholar Education Holdings’ $150m IPO in the US were covered as of Monday, according to bankers arranging the deal.
-
Ant Financial subsidiary Alipay (Hong Kong) Holding will increase the size of its $3bn loan, taken to partly support its bid to acquire Dallas-based MoneyGram, according to bankers. The news comes about a fortnight after Alipay raised its offer for MoneyGram by around $300m.
-
The IPO of VolkerWessels, the Dutch construction and property development company owned by the Wessels family, achieved coverage on its full deal size by Wednesday morning, two working days into the bookbuild.
-
Crystal International Group has filed a listing application with the Hong Kong Stock Exchange for a $600m-$800m IPO.
-
VolkerWessels, the Dutch construction company controlled by the Wessels family, has opened the books for its Amsterdam IPO, which could value the business at up to €2bn.
-
Pirelli, the Italian tyre maker owned by China National Chemical Corp (ChemChina), is pressing ahead with its plan to relist earlier than expected, due to favourable market dynamics.
-
Front and centre in a humming high yield bond market this week was Netflix, the US streaming service, which came to euros for the first time with a €1bn 10 year, dividing some investors on whether it was an attractive deal.
-
Shareholders of Sarana Menara Nusantara raised Rph5.4tr ($405.2m) from a re-IPO of the Indonesian company, selling the stock at the bottom of indications.
-
